基本信息
views: 141
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Kharasch leads an active research program in basic, translational and clinical pharmacology, and is a practicing anesthesiologist. His research broadly addresses anesthetic and analgesic drugs and addiction therapies, directed towards optimizing drug disposition, drug safety, clinical effectiveness and patient satisfaction. Specific interests include drug metabolism and transport, pharmacokinetics, pharmacodynamics, pharmacogenetics, toxicity, drug interactions, and variability in patient response, as well as perioperative pain and analgesia. His research led to the regulatory approval of sevoflurane, the most widely used volatile anesthetic in the world, having benefitted more than 1 billion patients. His research also focuses on the development and application of novel noninvasive biomarkers and nanotechnology-based molecular diagnostics. He is the author of more than 300 research papers, as well as numerous book chapters, and the editor of two major textbooks on anesthetic pharmacology. His research has been continuously federally funded for more than three decades.
Research Interests
Papers共 424 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Mayo Clinic Proceedingsno. 2 (2024): 198-202
Drug metabolism and disposition: the biological fate of chemicalsno. 3 (2024): 252-265
Anesthesia and analgesiano. 4 (2024): 906-908
Anesthesia and analgesiano. 5 (2024): 1145-1147
Drug metabolism and disposition: the biological fate of chemicalsno. 5 (2024): 455-466
Vijay K Ramaiah,Evan D Kharasch
Anesthesia and analgesia (2024)
MAYO CLINIC PROCEEDINGSno. 2 (2024): 198-202
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn